These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21572332)

  • 41. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
    De Schutter H; Geeraerts H; Verbeken E; Nuyts S
    Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of BRCA1 promoter methylation with rs11655505 (c.2265C>T) variants and decreased gene expression in sporadic breast cancer.
    Hasan TN; Leena Grace B; Shafi G; Syed R
    Clin Transl Oncol; 2013 Jul; 15(7):555-62. PubMed ID: 23263908
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens.
    Rice JC; Ozcelik H; Maxeiner P; Andrulis I; Futscher BW
    Carcinogenesis; 2000 Sep; 21(9):1761-5. PubMed ID: 10964110
    [TBL] [Abstract][Full Text] [Related]  

  • 44. BRCA1 promoter methylation is a marker of better response to anthracycline-based therapy in sporadic TNBC.
    Ignatov T; Poehlmann A; Ignatov A; Schinlauer A; Costa SD; Roessner A; Kalinski T; Bischoff J
    Breast Cancer Res Treat; 2013 Sep; 141(2):205-12. PubMed ID: 24026861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pyrosequencing quantified methylation level of BRCA1 promoter as prognostic factor for survival in breast cancer patient.
    Cai FF; Chen S; Wang MH; Lin XY; Zhang L; Zhang JX; Wang LX; Yang J; Ding JH; Pan X; Shao ZM; Biskup E
    Oncotarget; 2016 May; 7(19):27499-510. PubMed ID: 27027444
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular and epigenetic profiles of BRCA1-like hormone-receptor-positive breast tumors identified with development and application of a copy-number-based classifier.
    Chen Y; Wang Y; Salas LA; Miller TW; Mark K; Marotti JD; Kettenbach AN; Cheng C; Christensen BC
    Breast Cancer Res; 2019 Jan; 21(1):14. PubMed ID: 30683142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methylation of the BRCA1 promoter in peripheral blood DNA is associated with triple-negative and medullary breast cancer.
    Gupta S; Jaworska-Bieniek K; Narod SA; Lubinski J; Wojdacz TK; Jakubowska A
    Breast Cancer Res Treat; 2014 Dec; 148(3):615-22. PubMed ID: 25376744
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic and epigenetic characterization of the BRCA1 gene in Brazilian women at-risk for hereditary breast cancer.
    Felicio PS; Melendez ME; Arantes LM; Kerr LM; Carraro DM; Grasel RS; Campacci N; Scapulatempo-Neto C; Fernandes GC; de Carvalho AC; Palmero EI
    Oncotarget; 2017 Jan; 8(2):2850-2862. PubMed ID: 27926510
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methylation profiles of the BRCA1 promoter in hereditary and sporadic breast cancer among Han Chinese.
    Pang D; Zhao Y; Xue W; Shan M; Chen Y; Zhang Y; Zhang G; Liu F; Li D; Yang Y
    Med Oncol; 2012 Sep; 29(3):1561-8. PubMed ID: 22076508
    [TBL] [Abstract][Full Text] [Related]  

  • 50. BRCA1 promoter methylation is associated with increased mortality among women with breast cancer.
    Xu X; Gammon MD; Zhang Y; Bestor TH; Zeisel SH; Wetmur JG; Wallenstein S; Bradshaw PT; Garbowski G; Teitelbaum SL; Neugut AI; Santella RM; Chen J
    Breast Cancer Res Treat; 2009 May; 115(2):397-404. PubMed ID: 18521744
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics.
    Catteau A; Harris WH; Xu CF; Solomon E
    Oncogene; 1999 Mar; 18(11):1957-65. PubMed ID: 10208417
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigation of DNA damage response and apoptotic gene methylation pattern in sporadic breast tumors using high throughput quantitative DNA methylation analysis technology.
    Pal R; Srivastava N; Chopra R; Gochhait S; Gupta P; Prakash N; Agarwal G; Bamezai RN
    Mol Cancer; 2010 Nov; 9():303. PubMed ID: 21092294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methylation-related mutations in the BRCA1 promoter in peripheral blood cells from cancer-free women.
    Al-Moghrabi N; Al-Qasem AJ; Aboussekhra A
    Int J Oncol; 2011 Jul; 39(1):129-35. PubMed ID: 21537840
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of BRCA1 promoter methylation with sporadic breast cancers: Evidence from 40 studies.
    Zhang L; Long X
    Sci Rep; 2015 Dec; 5():17869. PubMed ID: 26643130
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Promoter methylation of BRCA1 in the prognosis of breast cancer: a meta-analysis.
    Wu L; Wang F; Xu R; Zhang S; Peng X; Feng Y; Wang J; Lu C
    Breast Cancer Res Treat; 2013 Dec; 142(3):619-27. PubMed ID: 24258259
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of BRCA1 Gene Promoter Methylation Status in Sporadic Breast Cancer Patients in Southwest of Iran.
    Hassani H; Talaiezadeh A; Tahmasebi Birgani M; Bijanzadeh M
    Asian Pac J Cancer Prev; 2023 Mar; 24(3):811-817. PubMed ID: 36974532
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer.
    Suijkerbuijk KP; Fackler MJ; Sukumar S; van Gils CH; van Laar T; van der Wall E; Vooijs M; van Diest PJ
    Ann Oncol; 2008 Nov; 19(11):1870-4. PubMed ID: 18647968
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
    Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
    Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females.
    Al-Moghrabi N; Nofel A; Al-Yousef N; Madkhali S; Bin Amer SM; Alaiya A; Shinwari Z; Al-Tweigeri T; Karakas B; Tulbah A; Aboussekhra A
    BMC Cancer; 2014 Nov; 14():830. PubMed ID: 25403427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene promoter methylation is associated with increased mortality among women with breast cancer.
    Xu X; Gammon MD; Zhang Y; Cho YH; Wetmur JG; Bradshaw PT; Garbowski G; Hibshoosh H; Teitelbaum SL; Neugut AI; Santella RM; Chen J
    Breast Cancer Res Treat; 2010 Jun; 121(3):685-92. PubMed ID: 19921426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.